279 related articles for article (PubMed ID: 23237420)
1. TACI mutations and impaired B-cell function in subjects with CVID and healthy heterozygotes.
Martinez-Gallo M; Radigan L; Almejún MB; Martínez-Pomar N; Matamoros N; Cunningham-Rundles C
J Allergy Clin Immunol; 2013 Feb; 131(2):468-76. PubMed ID: 23237420
[TBL] [Abstract][Full Text] [Related]
2. Transmembrane activator and calcium-modulating cyclophilin ligand interactor mutations in common variable immunodeficiency: clinical and immunologic outcomes in heterozygotes.
Zhang L; Radigan L; Salzer U; Behrens TW; Grimbacher B; Diaz G; Bussel J; Cunningham-Rundles C
J Allergy Clin Immunol; 2007 Nov; 120(5):1178-85. PubMed ID: 17983875
[TBL] [Abstract][Full Text] [Related]
3. Transmembrane activator and calcium-modulator and cyclophilin ligand interactor mutations in common variable immunodeficiency.
Lee JJ; Ozcan E; Rauter I; Geha RS
Curr Opin Allergy Clin Immunol; 2008 Dec; 8(6):520-6. PubMed ID: 18978466
[TBL] [Abstract][Full Text] [Related]
4. TACI, isotype switching, CVID and IgAD.
Castigli E; Geha RS
Immunol Res; 2007; 38(1-3):102-11. PubMed ID: 17917015
[TBL] [Abstract][Full Text] [Related]
5. CVID-associated TACI mutations affect autoreactive B cell selection and activation.
Romberg N; Chamberlain N; Saadoun D; Gentile M; Kinnunen T; Ng YS; Virdee M; Menard L; Cantaert T; Morbach H; Rachid R; Martinez-Pomar N; Matamoros N; Geha R; Grimbacher B; Cerutti A; Cunningham-Rundles C; Meffre E
J Clin Invest; 2013 Oct; 123(10):4283-93. PubMed ID: 24051380
[TBL] [Abstract][Full Text] [Related]
6. Three different classifications, B lymphocyte subpopulations, TNFRSF13B (TACI), TNFRSF13C (BAFF-R), TNFSF13 (APRIL) gene mutations, CTLA-4 and ICOS gene polymorphisms in Turkish patients with common variable immunodeficiency.
Kutukculer N; Gulez N; Karaca NE; Aksu G; Berdeli A
J Clin Immunol; 2012 Dec; 32(6):1165-79. PubMed ID: 22699762
[TBL] [Abstract][Full Text] [Related]
7. The murine equivalent of the A181E TACI mutation associated with common variable immunodeficiency severely impairs B-cell function.
Lee JJ; Rauter I; Garibyan L; Ozcan E; Sannikova T; Dillon SR; Cruz AC; Siegel RM; Bram R; Jabara H; Geha RS
Blood; 2009 Sep; 114(11):2254-62. PubMed ID: 19605846
[TBL] [Abstract][Full Text] [Related]
8. TNF receptor superfamily member 13b (TNFRSF13B) hemizygosity reveals transmembrane activator and CAML interactor haploinsufficiency at later stages of B-cell development.
Romberg N; Virdee M; Chamberlain N; Oe T; Schickel JN; Perkins T; Cantaert T; Rachid R; Rosengren S; Palazzo R; Geha R; Cunningham-Rundles C; Meffre E
J Allergy Clin Immunol; 2015 Nov; 136(5):1315-25. PubMed ID: 26100089
[TBL] [Abstract][Full Text] [Related]
9. Reduced BAFF-R and increased TACI expression in common variable immunodeficiency.
Barbosa RR; Silva SL; Silva SP; Melo AC; Pereira-Santos MC; Barata JT; Hammarström L; Cascalho M; Sousa AE
J Clin Immunol; 2014 Jul; 34(5):573-83. PubMed ID: 24809296
[TBL] [Abstract][Full Text] [Related]
10. A novel compound heterozygous TACI mutation in an autosomal recessive common variable immunodeficiency (CVID) family.
Lougaris V; Gallizzi R; Vitali M; Baronio M; Salpietro A; Bergbreiter A; Salzer U; Badolato R; Plebani A
Hum Immunol; 2012 Aug; 73(8):836-9. PubMed ID: 22627058
[TBL] [Abstract][Full Text] [Related]
11. Transmembrane activator and CAML interactor (TACI) haploinsufficiency results in B-cell dysfunction in patients with Smith-Magenis syndrome.
Chinen J; Martinez-Gallo M; Gu W; Cols M; Cerutti A; Radigan L; Zhang L; Potocki L; Withers M; Lupski JR; Cunningham-Rundles C
J Allergy Clin Immunol; 2011 Jun; 127(6):1579-86. PubMed ID: 21514638
[TBL] [Abstract][Full Text] [Related]
12. Novel mutations in TACI (TNFRSF13B) causing common variable immunodeficiency.
Mohammadi J; Liu C; Aghamohammadi A; Bergbreiter A; Du L; Lu J; Rezaei N; Amirzargar AA; Moin M; Salzer U; Pan-Hammarström Q; Hammarström L
J Clin Immunol; 2009 Nov; 29(6):777-85. PubMed ID: 19629655
[TBL] [Abstract][Full Text] [Related]
13. Genetics of common variable immunodeficiency: role of transmembrane activator and calcium modulator and cyclophilin ligand interactor.
Sathkumara HD; De Silva NR; Handunnetti S; De Silva AD
Int J Immunogenet; 2015 Aug; 42(4):239-53. PubMed ID: 26096648
[TBL] [Abstract][Full Text] [Related]
14. TACI regulates IgA production by APRIL in collaboration with HSPG.
Sakurai D; Hase H; Kanno Y; Kojima H; Okumura K; Kobata T
Blood; 2007 Apr; 109(7):2961-7. PubMed ID: 17119122
[TBL] [Abstract][Full Text] [Related]
15. The C104R mutant impairs the function of transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI) through haploinsufficiency.
Lee JJ; Jabara HH; Garibyan L; Rauter I; Sannikova T; Dillon SR; Bram R; Geha RS
J Allergy Clin Immunol; 2010 Dec; 126(6):1234-41.e2. PubMed ID: 20889194
[TBL] [Abstract][Full Text] [Related]
16. The C76R transmembrane activator and calcium modulator cyclophilin ligand interactor mutation disrupts antibody production and B-cell homeostasis in heterozygous and homozygous mice.
Bacchelli C; Buckland KF; Buckridge S; Salzer U; Schneider P; Thrasher AJ; Gaspar HB
J Allergy Clin Immunol; 2011 May; 127(5):1253-9.e13. PubMed ID: 21458042
[TBL] [Abstract][Full Text] [Related]
17. High serum levels of BAFF, APRIL, and TACI in common variable immunodeficiency.
Knight AK; Radigan L; Marron T; Langs A; Zhang L; Cunningham-Rundles C
Clin Immunol; 2007 Aug; 124(2):182-9. PubMed ID: 17556024
[TBL] [Abstract][Full Text] [Related]
18. Lack of Gut Secretory Immunoglobulin A in Memory B-Cell Dysfunction-Associated Disorders: A Possible Gut-Spleen Axis.
Carsetti R; Di Sabatino A; Rosado MM; Cascioli S; Piano Mortari E; Milito C; Grimsholm O; Aranburu A; Giorda E; Tinozzi FP; Pulvirenti F; Donato G; Morini F; Bagolan P; Corazza GR; Quinti I
Front Immunol; 2019; 10():2937. PubMed ID: 31969880
[No Abstract] [Full Text] [Related]
19. Molecular basis of common variable immunodeficiency.
Castigli E; Geha RS
J Allergy Clin Immunol; 2006 Apr; 117(4):740-6; quiz 747. PubMed ID: 16630927
[TBL] [Abstract][Full Text] [Related]
20. Analysis of TACI mutations in CVID & RESPI patients who have inherited HLA B*44 or HLA*B8.
Waldrep ML; Zhuang Y; Schroeder HW
BMC Med Genet; 2009 Sep; 10():100. PubMed ID: 19775471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
